NCT04362813 · Interventional trial
Study of Efficacy and Safety of Canakinumab Treatment for CRS in Participants With COVID-19-induced Pneumonia
Overall registry status Completed
Phase 3
Conditions Cytokine Release Syndrome (CRS) in Patients With COVID-19-induced Pneumonia
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory